Skip to main content
Log in

Functional consequences following methamphetamine-induced neuronal damage

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The functional consequences following methamphetamine-induced neuronal damage were evaluated under several different conditions known to affect the magnitude of the lesion. It was found that methamphetamine (6.25 mg/kg administered SC, four times at 2-h intervals) caused long-lasting depletions of striatal dopamine and serotonin and that pretreatment with the antioxidant, ascorbic acid (100 mg/kg), attenuated these depletions, whereas pretreatment with the superoxide dismutase inhibitor diethyldithiocarbamate (200 mg/kg) exacerbated these depletions. The dopamine depletions resulting from the repeated administration of methamphetamine under these various conditions did not result in any alteration in the consumption of a sweetened-condensed milk solution under baseline conditions. However, when these lesioned animals were challenged with acutely administered methamphetamine, it was observed that there was an altered sensitivity to the milk intake decreasing effects of this compound. That is, the degree to which the acutely administered methamphetamine reduced the intake of sweetened-condensed milk was highly correlated with the magnitude of the methamphetamine-induced dopamine and serotonin depletions. These observations support the hypothesis that methamphetamine-induced neuronal damage is mediated by free radical formation and indicate that behavioral measures may be employed to assess neuronal damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ando K, Johanson CE, Seiden LS, Schuster CR (1984) Sensitivity changes to dopamine agents in fine motor control of rhesus monkeys after repeated methamphetamine administration. Pharmacol Biochem Behav 22:737–743.

    Google Scholar 

  • Bittner SE, Wagner GC, Aigner TG, Seiden LS (1981) Effects of a high dose treatment of methamphetamine on caudate dopamine and anorexia in rats. Pharmacol Biochem Behav 14:481–486.

    Google Scholar 

  • Commins DE, Axt KJ, Vosmer G, Seiden LS (1987) 5,6-Dihydroxytryoptamine, a serotonergic neurotoxin, is formed endogenously in the rat brain. Brain Res 403:7–14.

    Google Scholar 

  • Finnegan KT, Ricaurte GA, Seiden LS, Schuster CR (1980) Altered sensitivity to d-methamphetamine, apomorphine and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methamphetamine. Psychopharmacology 77:43–52.

    Google Scholar 

  • Hadjiconstatinou H, Neff NH (1983) Ascorbic acid could be hazardous to your experiments: a commentary on dopamine receptor binding studies with a speculation on a role for ascorbic acid in neuronal function. Neuropharmacology 22:939–943.

    Google Scholar 

  • Kogan FJ, Nichols WK, Gibb JW (1976) Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striaal dopamine levels. Eur J Pharmacol 36:363–371.

    Google Scholar 

  • Lucot JB, Wagner GC, Schuster CR, Seiden LS (1980) Effects of dopaminergic agents on the locomotor activity of rats after high doses of methamphetamine. Pharmacol Biochem Behav 13:409–413.

    Google Scholar 

  • Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY (1982) Dopamine nerve terminal degeneration produced by high doses of methamphetamine in the rat brain. Brain Res 235:93–103.

    Google Scholar 

  • Seiden LS, Vosmer G (1984) Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methamphetamine. Pharmacol Biochem Behav 21:29–31.

    Google Scholar 

  • Wagner GC, Seiden LS, Schuster CR (1979) Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs. Drug Alcohol Depend 4:435–438.

    Google Scholar 

  • Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller JM, Westly J (1980) Long-lasting depletion of striatal dopamine and loss of dopamine uptake sites following the repeated administration of methamphetamine. Brain Res 181:151–160.

    Google Scholar 

  • Wagner GC, Gardner J, Tsigas J, Masters DB (1984) Tolerance following the repeated administration of high doses of phencyclidine: no relation to central catecholamine depletion. Drug Alcohol Depend 13:225–234.

    Google Scholar 

  • Wagner GC, Carelli RM, Jarvis MJ (1985) Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res Commun Chem Pathol Pharmacol 47:221–228.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Vito, M.J., Wagner, G.C. Functional consequences following methamphetamine-induced neuronal damage. Psychopharmacology 97, 432–435 (1989). https://doi.org/10.1007/BF00439543

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00439543

Key words

Navigation